Browsing by Author Tu, Dongsheng

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)Citation
2013Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17Pavlakis, Nick; Simes, Robert John; Blondal, J; Burkes, R L; Gibbs, Peter; Jonker, D; Karapetis, Christos; Lee, U; Meharchand, J; Moore, Malcolm; O'Callaghan, Chris; Price, T.J.; Rubin, S; Shapiro, Jeremy; Tebbutt, Niall C; Tu, Dongsheng; van Hazel, Guy; Vickers, M; Zalcberg, John; Zhu, L; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreAssociation of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17, Annals of Oncology, vol.24, 4, 2013,pp 953-960
2007Cetuximab for the Treatment of Colorectal CancerSimes, Robert John; Zalcberg, John; Au, Heather Jane; Berry, Scott R.; et, al; Jonker, Derek J.; Karapetis, Christos (Chris); Krahn, Marianne; O’Callaghan, Chris J.; Price, Timothy; Tebbutt, Niall C; Tu, Dongsheng; van Hazel, Guy; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreCetuximab for the Treatment of Colorectal Cancer, New England Journal of Medicine, vol.357,(20),2007,pp 2040-2048
2008The Colon Health and Life-Long Exercise Change trial: a randomized trial of the National Cancer Institute of Canada Clinical Trials GroupDhillon, Haryana; Vardy, Janette; Au, Heather Jane; Booth, C.M.; Brundage, M.D.; Courneya, Kerry; Friedenreich, Christine; Gill, S; Meyer, Ralph.M.; O'Brien, P; Tu, Dongsheng; Psychology; Concord Clinical School: MedicineThe Colon Health and Life-Long Exercise Change trial: a randomized trial of the National Cancer Institute of Canada Clinical Trials Group, Current Oncology, vol.15, 6, 2008,pp 8-16
2014Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancerSimes, Robert John; et al, Various; Harbison, C; Jonker, Derek J.; Karapetis, Christos (Chris); Langer, C; Malone, DP; O’Callaghan, C; Price, Timothy; Shapiro, J; Tebbutt, Niall; Tu, Dongsheng; School of Public Health: NH&MRC Clinical Trials CentreEpiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer, British Journal of Cancer, vol.110, 3, 2014,pp 648-655
2009Health-related quality of life in patients with advanced colorectal cancer treated with cetuximab: overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 Trial.Pavlakis, Nick; Au, Heather-Jane; et al, various; Jefford, Michael; Karapetis, Christos; Kennecke, Hagen; Koski, Sherryl; Moore, M J; O'Callaghan, Chris; Shapiro, Jeremy; Tu, Dongsheng; Zalcberg, John; Northern Clinical School: MedicineHealth-related quality of life in patients with advanced colorectal cancer treated with cetuximab: overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 Trial., Journal of Clinical Oncology, vol.27, 11,pp 1822-1828
2014The relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17Simes, Robert John; Sommeijer, Dirkje; Jonker, Derek J.; Karapetis, Christos; O’CALLAGHAN, Chris; Price, Timothy; Tebbutt, Niall; Tu, Dongsheng; Yip, Desmond; Zalcberg, John; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreThe relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17, Acta Oncologica, vol.53, 7, 2014,pp 877-884
2016Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3Lee, Chee Khoon; Au, Heather Jane; Brundage, M.D.; Goldstein, David; Jonker, Derek J.; Moore, Malcolm J.; O'Callaghan, Chris J.; Parulekar, Wendy R.; Ringash, Jolie; Tu, Dongsheng; Vickers, Michael M.; Wheatley-Price, Paul; NH&MRC Clinical Trials CentreSignificance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3, Pancreatology, vol.16, 6, 2016,pp 1106-1112